Antituberculosis Drug Reclassification for Proper Management of Rifampicin-resistant and Multidrug-resistant Tuberculosis | Zendy

AI Assistant Blog Pricing

Open Access

Antituberculosis Drug Reclassification for Proper Management of Rifampicin-resistant and Multidrug-resistant Tuberculosis

Author(s) -

Suhail Ahmad

Publication year - 2018

Publication title -

journal of bacteriology and parasitology

Language(s) - English

Resource type - Journals

ISSN - 2155-9597

DOI - 10.4172/2155-9597.1000e129

Subject(s) - tuberculosis , rifampicin , medicine , multiple drug resistance , drug , multi drug resistant , drug resistance , intensive care medicine , pharmacology , biology , microbiology and biotechnology , pathology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Download on the

Discover

Explore

Copyright Knowledge E © 2026. All Rights Reserved.